These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25089269)

  • 41. A possible strategy against head and neck cancer: in silico investigation of three-in-one inhibitors.
    Tsou YA; Chen KC; Chang SS; Wen YR; Chen CY
    J Biomol Struct Dyn; 2013 Dec; 31(12):1358-69. PubMed ID: 23140436
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In silico investigation of traditional Chinese medicine compounds to inhibit human histone deacetylase 2 for patients with Alzheimer's disease.
    Hung TC; Lee WY; Chen KB; Chan YC; Lee CC; Chen CY
    Biomed Res Int; 2014; 2014():769867. PubMed ID: 25045700
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Insights from molecular dynamics simulations and steered molecular dynamics simulations to exploit new trends of the interaction between HIF-1α and p300.
    Yu Z; Liu Y; Zhu J; Han J; Tian X; Han W; Zhao L
    J Biomol Struct Dyn; 2020 Jan; 38(1):1-12. PubMed ID: 30784357
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A structural perspective on the interactions of TRAF6 and Basigin during the onset of melanoma: A molecular dynamics simulation study.
    Biswas R; Ghosh S; Bagchi A
    J Mol Recognit; 2017 Nov; 30(11):. PubMed ID: 28612997
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Jianpi Jiedu decoction, a traditional Chinese medicine formula, inhibits tumorigenesis, metastasis, and angiogenesis through the mTOR/HIF-1α/VEGF pathway.
    Peng W; Zhang S; Zhang Z; Xu P; Mao D; Huang S; Chen B; Zhang C; Zhang S
    J Ethnopharmacol; 2018 Oct; 224():140-148. PubMed ID: 29852266
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Traditional Chinese medicine application in HIV: an in silico study.
    Huang HJ; Jian YR; Chen CY
    J Biomol Struct Dyn; 2014; 32(1):1-12. PubMed ID: 23252879
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combining in silico and in vitro approaches to identification of potent inhibitor against phospholipase A2 (PLA2).
    Chinnasamy S; Selvaraj G; Selvaraj C; Kaushik AC; Kaliamurthi S; Khan A; Singh SK; Wei DQ
    Int J Biol Macromol; 2020 Feb; 144():53-66. PubMed ID: 31838071
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of rheumatoid arthritis with traditional chinese medicine.
    Lee WY; Chen HY; Chen KC; Chen CY
    Biomed Res Int; 2014; 2014():528018. PubMed ID: 24991562
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
    Mishra V; Pathak C
    J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structural Insights into mitochondrial antiviral signaling protein (MAVS)-tumor necrosis factor receptor-associated factor 6 (TRAF6) signaling.
    Shi Z; Zhang Z; Zhang Z; Wang Y; Li C; Wang X; He F; Sun L; Jiao S; Shi W; Zhou Z
    J Biol Chem; 2015 Oct; 290(44):26811-20. PubMed ID: 26385923
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In silico identification of potent pancreatic triacylglycerol lipase inhibitors from traditional Chinese medicine.
    Chen KY; Chang SS; Chen CY
    PLoS One; 2012; 7(9):e43932. PubMed ID: 22970152
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discovery of small molecule CD40-TRAF6 inhibitors.
    Zarzycka B; Seijkens T; Nabuurs SB; Ritschel T; Grommes J; Soehnlein O; Schrijver R; van Tiel CM; Hackeng TM; Weber C; Giehler F; Kieser A; Lutgens E; Vriend G; Nicolaes GA
    J Chem Inf Model; 2015 Feb; 55(2):294-307. PubMed ID: 25622654
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structure-Based Development of a Protein-Protein Interaction Inhibitor Targeting Tumor Necrosis Factor Receptor-Associated Factor 6.
    Moriya J; Takeuchi K; Tai K; Arai K; Kobayashi N; Yoneda N; Fukunishi Y; Inoue A; Kihara M; Murakami T; Chiba K; Shimada I
    J Med Chem; 2015 Jul; 58(14):5674-83. PubMed ID: 26132273
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Virtual screening of traditional Chinese medicine (TCM) database: identification of fragment-like lead molecules for filariasis target asparaginyl-tRNA synthetase.
    Arya H; Coumar MS
    J Mol Model; 2014 Jun; 20(6):2266. PubMed ID: 24842326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discovery of promising FtsZ inhibitors by E-pharmacophore, 3D-QSAR, molecular docking study, and molecular dynamics simulation.
    Qiu Y; Zhou L; Hu Y; Bao Y
    J Recept Signal Transduct Res; 2019 Apr; 39(2):154-166. PubMed ID: 31355691
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epigallocatechin-3-gallate(EGCG) suppresses melanoma cell growth and metastasis by targeting TRAF6 activity.
    Zhang J; Lei Z; Huang Z; Zhang X; Zhou Y; Luo Z; Zeng W; Su J; Peng C; Chen X
    Oncotarget; 2016 Nov; 7(48):79557-79571. PubMed ID: 27791197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Folic Acid Exerts Post-Ischemic Neuroprotection In Vitro Through HIF-1α Stabilization.
    Davis CK; Nampoothiri SS; Rajanikant GK
    Mol Neurobiol; 2018 Nov; 55(11):8328-8345. PubMed ID: 29542054
    [TBL] [Abstract][Full Text] [Related]  

  • 58. iScreen: world's first cloud-computing web server for virtual screening and de novo drug design based on TCM database@Taiwan.
    Tsai TY; Chang KW; Chen CY
    J Comput Aided Mol Des; 2011 Jun; 25(6):525-31. PubMed ID: 21647737
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of new benzamide inhibitor against α-subunit of tryptophan synthase from Mycobacterium tuberculosis through structure-based virtual screening, anti-tuberculosis activity and molecular dynamics simulations.
    Naz S; Farooq U; Ali S; Sarwar R; Khan S; Abagyan R
    J Biomol Struct Dyn; 2019 Mar; 37(4):1043-1053. PubMed ID: 29502488
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exploration of New and Potent Lead Molecules Against CAAX Prenyl Protease I of Leishmania donovani Through Pharmacophore Based Virtual Screening Approach.
    Prabhu SV; Tiwari K; Suryanarayanan V; Dubey VK; Singh SK
    Comb Chem High Throughput Screen; 2017; 20(3):255-271. PubMed ID: 28116998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.